Virtus Investment Advisers, Inc. - Q1 2017 holdings

$1.13 Billion is the total value of Virtus Investment Advisers, Inc.'s 481 reported holdings in Q1 2017. The portfolio turnover from Q4 2016 to Q1 2017 was - .

 Value Shares↓ Weighting
CBRE NewCBRE GROUP INCcl a$10,739,000308,691
+100.0%
0.95%
EMB NewISHARES TRjp mor em mk etf$6,160,00054,181
+100.0%
0.54%
EWY NewISHARESmsci sth kor etf$4,174,00067,467
+100.0%
0.37%
NewING GROEP N Vdbcv 6.000%12/3$2,996,0003,000,000
+100.0%
0.26%
HYG NewISHARES TRiboxx hi yd etf$2,076,00023,650
+100.0%
0.18%
PG NewPROCTER AND GAMBLE CO$2,060,00022,927
+100.0%
0.18%
JNJ NewJOHNSON & JOHNSON$1,962,00015,756
+100.0%
0.17%
KO NewCOCA COLA CO$1,404,00033,072
+100.0%
0.12%
PFE NewPFIZER INC$1,197,00035,004
+100.0%
0.11%
MRK NewMERCK & CO INC$1,018,00016,021
+100.0%
0.09%
WMT NewWAL-MART STORES INC$927,00012,866
+100.0%
0.08%
PEP NewPEPSICO INC$790,0007,064
+100.0%
0.07%
CVS NewCVS HEALTH CORP$734,0009,347
+100.0%
0.06%
AMGN NewAMGEN INC$714,0004,354
+100.0%
0.06%
LLL NewL3 TECHNOLOGIES INC$699,0004,231
+100.0%
0.06%
WBA NewWALGREENS BOOTS ALLIANCE INC$651,0007,834
+100.0%
0.06%
COST NewCOSTCO WHSL CORP NEW$657,0003,918
+100.0%
0.06%
ABBV NewABBVIE INC$615,0009,441
+100.0%
0.05%
CL NewCOLGATE PALMOLIVE CO$583,0007,969
+100.0%
0.05%
AGN NewALLERGAN PLC$554,0002,317
+100.0%
0.05%
CELG NewCELGENE CORP$558,0004,486
+100.0%
0.05%
BMY NewBRISTOL MYERS SQUIBB CO$527,0009,694
+100.0%
0.05%
GILD NewGILEAD SCIENCES INC$518,0007,633
+100.0%
0.05%
LLY NewLILLY ELI & CO$474,0005,637
+100.0%
0.04%
KMB NewKIMBERLY CLARK CORP$427,0003,243
+100.0%
0.04%
IDXX NewIDEXX LABS INC$376,0002,433
+100.0%
0.03%
BIIB NewBIOGEN INC$348,0001,272
+100.0%
0.03%
KR NewKROGER CO$270,0009,164
+100.0%
0.02%
ADM NewARCHER DANIELS MIDLAND CO$240,0005,207
+100.0%
0.02%
ESRX NewEXPRESS SCRIPTS HLDG CO$242,0003,673
+100.0%
0.02%
MNST NewMONSTER BEVERAGE CORP NEW$180,0003,889
+100.0%
0.02%
MCK NewMCKESSON CORP$179,0001,205
+100.0%
0.02%
EL NewLAUDER ESTEE COS INCcl a$176,0002,070
+100.0%
0.02%
DPS NewDR PEPPER SNAPPLE GROUP INC$173,0001,770
+100.0%
0.02%
REGN NewREGENERON PHARMACEUTICALS$164,000424
+100.0%
0.02%
CLX NewCLOROX CO DEL$166,0001,231
+100.0%
0.02%
CAH NewCARDINAL HEALTH INC$143,0001,748
+100.0%
0.01%
VRTX NewVERTEX PHARMACEUTICALS INC$145,0001,324
+100.0%
0.01%
ALXN NewALEXION PHARMACEUTICALS INC$149,0001,225
+100.0%
0.01%
ZTS NewZOETIS INCcl a$143,0002,687
+100.0%
0.01%
HCA NewHCA HOLDINGS INC$140,0001,570
+100.0%
0.01%
CHD NewCHURCH & DWIGHT INC$98,0001,969
+100.0%
0.01%
MYL NewMYLAN N V$94,0002,413
+100.0%
0.01%
CERN NewCERNER CORP$91,0001,552
+100.0%
0.01%
WFM NewWHOLE FOODS MKT INC$78,0002,639
+100.0%
0.01%
ABC NewAMERISOURCEBERGEN CORP$77,000873
+100.0%
0.01%
LH NewLABORATORY CORP AMER HLDGS$74,000513
+100.0%
0.01%
XRAY NewDENTSPLY SIRONA INC$72,0001,155
+100.0%
0.01%
HSIC NewSCHEIN HENRY INC$67,000396
+100.0%
0.01%
DGX NewQUEST DIAGNOSTICS INC$70,000711
+100.0%
0.01%
COTY NewCOTY INC$61,0003,380
+100.0%
0.01%
DVA NewDAVITA INC$51,000747
+100.0%
0.01%
UHS NewUNIVERSAL HLTH SVCS INCcl b$53,000426
+100.0%
0.01%
PRGO NewPERRIGO CO PLC$43,000654
+100.0%
0.00%
COO NewCOOPER COS INC$45,000224
+100.0%
0.00%
EVHC NewENVISION HEALTHCARE CORP$34,000550
+100.0%
0.00%
PDCO NewPATTERSON COMPANIES INC$6,000139
+100.0%
0.00%
MNKKQ NewMALLINCKRODT PUB LTD CO$13,000287
+100.0%
0.00%
Original filings

The following EDGAR filing(s) were analyzed to create this report:

  • View 13F-HR filed 2017-05-15
Signatures

The EDGAR filing(s) were signed by:

Top long-term holdings
NameQuarters ownedLatest quarter ownedMax weighting
ISHARES TR21Q3 202396.6%
ISHARES TR19Q3 202097.5%
ISHARES INC16Q4 20170.8%
SELECT SECTOR SPDR TR13Q4 201618.9%
ISHARES13Q4 20170.4%
SPDR SERIES TRUST12Q4 201839.4%
SELECT SECTOR SPDR TR12Q4 201616.6%
SELECT SECTOR SPDR TR11Q3 201617.8%
SELECT SECTOR SPDR TR11Q4 201616.9%
SELECT SECTOR SPDR TR11Q4 201616.1%

View Virtus Investment Advisers, Inc.'s complete holdings history.

Latest significant ownerships (13-D/G)

View Virtus Investment Advisers, Inc.'s complete significant-ownership history.

Latest filings
TypeFiled
13F-HR2024-05-16
13F-HR2024-02-15
13F-HR2023-11-08
13F-HR2023-08-14
13F-HR2023-05-15
13F-HR2023-02-14
13F-HR2022-11-14
13F-NT2022-08-12
13F-NT2022-05-16
13F-NT2022-02-14

View Virtus Investment Advisers, Inc.'s complete filings history.

Compare quarters

Export Virtus Investment Advisers, Inc.'s holdings